Azienda Unita Sanitaria Locale Di Bologna

4 trials 1 recruiting Academic / non-commercial

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

7 Unique IMPs

N/A Results reported

Phase III

Phase IV

Phase III: 2 Phase IV: 2

Top indications

Ischaemic stroke 1 Septic shock 1 Prolactin-producing pituitary tumour 1

Top IMPs

ACETYLSALICYLIC ACID 1 ARGIPRESSIN 1 CABERGOLINE 1 CLOPIDOGREL 1 HUMAN FIBRINOGEN 1 SULFUR HEXAFLUORIDE 1 TICLOPIDINE HYDROCHLORIDE 1

All trials

4 total

Surgical versus Medical Treatment in Microprolactinomas (SUMET PRO) Pending

2024-516383-28-01 Phase III 1 country CABERGOLINE
FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLL… Pending

2024-516731-27-00 Phase III 1 country HUMAN FIBRINOGEN
Tailored antiplatelet secondary prevention in non-cardioembolic ischemic stroke: a phase IV gender-stratified randomized controlled trial (T… Pending

2025-523065-16-00 Phase IV 1 country ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE HYDROCHLORIDE
Renal Outcomes in the early use of vasopressin in the treatment of septic shock Recruiting

2023-509071-16-00 Phase IV 1 country ARGIPRESSIN; SULFUR HEXAFLUORIDE

Showing 1–4 of 4 trials

← All sponsors A–Z